Author Question: The nurse who has received special training to administer chemotherapy is called: 1. an ... (Read 39 times)

future617RT

  • Hero Member
  • *****
  • Posts: 543
The nurse who has received special training to administer chemotherapy is called:
 
  1. an antineoplastic administrator.
  2. a chemotherapy nurse.
  3. an oncology nurse.
  4. an IV therapy nurse.

Question 2

The nurse anticipates administering which drug to stimulate neutrophil production in clients with myelosuppression?
 
  1. Epoetin
  2. Interferon alfa
  3. Filgrastim
  4. Oprelvekin



bob

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

Correct Answer: 3
Rationale 1: This type of nurse is not called an antineoplastic administrator.
Rationale 2: This type of nurse is not called a chemotherapy nurse.
Rationale 3: This type of nurse is called an oncology nurse.
Rationale 4: This type of nurse is not called an IV therapy nurse.
Global Rationale: Oncology nurses have taken specific education to fulfill their role. The other terms do not explain this training.

Answer to Question 2

Correct Answer: 3
Rationale 1: Epoetin stimulates the production of RBCs.
Rationale 2: Interferon alfa is a biologic response modifier used to treat cancer.
Rationale 3: This is the correct answer.
Rationale 4: Oprelvekin stimulates the production of platelets.
Global Rationale: Colony stimulating factors such as filgrastim (Neupogen) increase neutrophil production in the bone marrow and enhance the phagocytic and cytotoxic functions of existing neutrophils. Epoetin stimulates production of RBCs and oprelvekin stimulates production of platelets. Interferon alfa does not affect cell colony growth.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

The FDA recognizes 118 routes of administration.

For a complete list of videos, visit our video library